Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-01-09. Active
26 1090 1056 0000 0001 6466 4255- 38 1090 1056 0000 0001 6464 3669
- 73 1090 1056 0000 0001 6466 4670
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
29 public aid cases recorded, with a total value of $4,343,572.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 17, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $4,295$4,295 | Agencja Rozwoju Pomorza S.A. | |
| May 20, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $20,800$20,800 | Agencja Rozwoju Pomorza S.A. | |
| Oct 22, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $904$904 | Agencja Rozwoju Pomorza S.A. |
European Funds
4 projects co-financed from European Funds recorded, with total EU co-financing of $5,140,146.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-01-01 | GUTAron: Optymalizacja leczenia zespołu nadmiernego rozrostu bakterii (SIBO) poprzez wykorzystanie naturalnych składników roślinnych bogatych w polifenole w połączeniu z enzymami trawiennymi jako produktu wspierającego antybiotykoterapię lub dietoterapię low FODMAP. | $2.5M$2,501,152 | Fundusze Europejskie dla Nowoczesnej Gospodarki | |
| 2020-10-01 | Naturalne wsparcie układu odpornościowego organizmu jako sposób prewencji skutków działania wirusa Sars-CoV-2. | $1.1M$1,110,622 | Program Operacyjny Inteligentny Rozwój | |
| 2020-01-01 | Innowacyjne preparaty polifenolowe pozyskane z owoców jagodowych wykorzystywane w prewencji i profilaktyce skutków ubocznych terapii onkologicznej, chemio i radioterapii | $757.2K$757,242 | Regionalny Program Operacyjny Województwa Pomorskiego na lata 2014-2020 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board independently is authorised to make declarations on behalf of the company. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ewa Fijołek (43) | 49 | $661.80 | 12.25% |
Greenvit Sp. z o.o. | 98 | $1,323.61 | 24.5% |
Krzysztof Kazimierz Lemke (49) | 120 | $1,620.75 | 30% |
Anna Pietruszyńska (39) | 44 | $594.27 | 11% |
Bartosz Pietruszyński (28) | 66 | $891.41 | 16.5% |
Others | 23 | $310.64 | 5.75% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Krzysztof Kazimierz Lemke (49)  | Shareholder of a limited liability company, 5000.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| Phage Consultantssp. z o.o. | $193,130.82 | phageconsultants.com | ||
| Pominnosp. z o.o. | $65,991.17 | pominno.pl | ||
| Receptonsp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | ||
| ArthecS.A. | $10,911.16 | arthec.eu | ||
| MAP Your Dna Spólka z Ograniczoną Odpowiedzialnościąsp. z o.o. | $7,283.38 | mapyourdna.eu | ||
| Innervisionsp. z o.o. | $4.54 | innervision.pl | ||
| UrtesteS.A. | – | urteste.com | ||
| Astrofoodssp. z o.o. | – | astrofarms.space |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-01 | Share capital change (10,000.00 PLN → 20,000.00 PLN) | |
| 2022-06-30 | Share capital change (6,550.00 PLN → 10,000.00 PLN) | |
| 2020-11-05 | PKD change (Added: 10.89.Z) | |
| 2019-03-20 | Share capital change (5,100.00 PLN → 6,550.00 PLN) | |
| 2018-12-11 | Entered in the register |
FAQ
Last updated: 2026-07-04